Posted by rafaelc 23 hours ago
The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.
It won’t cure people with metastatic disease, but it will help a lot live better lives for longer.
Not true. The folfirinox chemo regimen was invented a couple of years ago, and it significantly increased the life expectancy and quality of life for terminal pancreatic cancer patients.[0]
Cancer is a problem that can be solved, and it needs to be solved asap. Cancer too often gets either relegated to "Actually, statistically it's very unlikely" by people who don't have it or stylized to the God of Death that unlike other illness we won't solve anytime soon. There is no time to be lost tackling with AI. Dario gets it. Had cancer himself and his father passed away from it.
Unless we can reliably sign our cells like we do our binaries, we ain't "solving" cancer.
Am I missing something?
From other sources:
> Median overall survival: 13.2 months versus about 6.6 to 6.7 months with chemotherapy.
Merely counting months does not do much - you'd have to count the quality of these months too.
I don't see that as a breakthrough.
If we can prove GRH with AI we really should be able to cure cancer.
Pancreatic cancer halted by virus injection in three patients - https://news.ycombinator.com/item?id=50563066 - Nov 2026 (157 comments)